High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial – The Lancet Respiratory Medicine (free registration required)   Commentary on Twitter NEW Research—In critically ill immunocompromised patients with acute respiratory failure, the mortality rate did not differ between HFNO alone and NIV […]

The post RCT: In critically ill immunocompromised patients with acute respiratory failure, outcomes were similar with the use of high-flow nasal oxygen alone vs. alternating with non-invasive ventilation. appeared first on Links Medicus.